Vericel获BARDA高达1.97亿美元合同,用于采购与深度开发Nexobrid

美股速递
Apr 03

Vericel Corporation(简称Vericel)宣布,已获得美国生物医学高级研究与发展管理局(BARDA)授予的一份重要合同。该合同价值高达1.97亿美元,旨在支持其创新产品Nexobrid的采购及后续的深度开发工作。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10